Literature DB >> 11242587

Residents' preparation for and ability to manage ethical conflicts in Korean residency programs.

Y Koh1.   

Abstract

The doctor-patient relationship in Korea has been deteriorating, and the numbers of malpractice suits and other medical disputes have been increasing annually for the past decade. Part of the problem may be physicians' lack of ethics education. The author and colleagues surveyed Korean residents from 14 university hospitals and found that most regularly experienced serious ethical dilemmas and had difficulty appropriately managing them. Few were familiar with medical law, and many resolved ethical conflicts either on their own or by talking with colleagues. Many did not follow guidelines for obtaining informed consent. Few had ethics committees or consultants available to them, and most did not discuss ethical dilemmas with attending physicians. The author describes the kinds of dilemmas faced by Korean residents and how they manage them, and he offers recommendations for improving ethics education and the ethics environment for Korean medical students and residents.

Entities:  

Keywords:  Bioethics and Professional Ethics; Empirical Approach; Professional Patient Relationship

Mesh:

Year:  2001        PMID: 11242587     DOI: 10.1097/00001888-200103000-00025

Source DB:  PubMed          Journal:  Acad Med        ISSN: 1040-2446            Impact factor:   6.893


  3 in total

1.  Need for enforcement of ethicolegal education - an analysis of the survey of postgraduate clinical trainees.

Authors:  Mayumi Mayeda; Kozo Takase
Journal:  BMC Med Ethics       Date:  2005-08-06       Impact factor: 2.652

Review 2.  Hospital/clinical ethics committees' notion: an overview.

Authors:  Fatemeh Hajibabaee; Soodabeh Joolaee; Mohammad Ali Cheraghi; Pooneh Salari; Patricia Rodney
Journal:  J Med Ethics Hist Med       Date:  2016-12-18

3.  Which are the most prevalent ethical conflicts for Spanish internists?

Authors:  A Blanco Portillo; R García-Caballero; D Real de Asúa; B Herreros
Journal:  Rev Clin Esp       Date:  2020-07-07       Impact factor: 1.556

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.